NuCana plc American Depositary Share
Symbol: NCNA (NASDAQ)
3.32
▲ (13.53%) 0.395
Company Description:
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
Key Stats
- Today's Open: $2.91
- Today's High: $3.36
- Today's Low: $2.755
- Today's Volume: 455.77K
- Yesterday Close: $2.92
- Yesterday High: $2.99
- Yesterday Low: $2.85
- Yesterday Volume: 191.63K
- Last Min Volume: 300
- Last Min High: $3.315
- Last Min Low: $3.252
- Last Min VWAP: $3.2625
Company Profile
- Name: NuCana plc American Depositary Share
- Website: https://www.nucana.com
- Listed Date: 2017-09-28
- Location: ,
- Market Status: Active
- CIK Number: 0001709626
- SIC Code:
- SIC description:
- Market Cap: $5.51M
- Round Lot: 100
- Outstanding Shares: 1.91M
- Asset Type: ADRC
RECENT FILINGS FOR NCNA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-05 | 6-K | View |
| 2025-09-03 | 6-K | View |
| 2025-08-20 | 6-K | View |
| 2025-08-01 | 6-K | View |
| 2025-07-21 | 6-K | View |
| 2025-07-16 | F-6 POS | View |
| 2025-07-11 | 6-K | View |
| 2025-07-09 | 6-K | View |
| 2025-06-30 | 6-K | View |
| 2025-06-27 | 424B5 | View |
| 2025-06-27 | 6-K | View |
| 2025-06-24 | EFFECT | View |
| 2025-06-20 | CORRESP | View |
| 2025-06-20 | 6-K | View |
| 2025-06-18 | F-3/A | View |
| 2025-06-18 | 6-K | View |
| 2025-06-13 | UPLOAD | View |
| 2025-06-05 | 6-K | View |
| 2025-06-02 | 6-K | View |
| 2025-05-07 | 424B4 | View |
Latest News on NCNA